Tang Chun Wai Nelson
@Nan Fung Group Holdings Ltd
Latest period2024 - Q3ReportedManaged Assets$116.07MTotal holdings38
Assets growth rate23.84%Assets growth rate (2-Q avg)5.35%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Nan Fung Group Holdings Ltd's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 38 positions.
Assets under management
The assets under management (AUM) of Nan Fung Group Holdings Ltd over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 116.07M in assets, with a quarterly growth rate of 23.84% and a 2-quarter average growth rate of 5.35%. The portfolio is managed by Tang Chun Wai Nelson, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
EXAIExscientia Plc
| 3.62% | $4.196M 859,892 shares@ $4.89 avg price | |
MIRMMirum Pharmaceuticals Inc
| 3.57% | $4.138M 106,100 shares@ $39.0 avg price | |
TRMLTourmaline Bio Inc
| 3.26% | $3.774M 146,800 shares@ $25.71 avg price | |
LABStandard Biotools Inc
| 3.14% | $3.635M 1.883M shares@ $1.93 avg price | |
SLNOSoleno Therapeutics Inc
| 2.79% | $3.229M 63,950 shares@ $50.5 avg price | New Position |
REPLReplimune Group Inc
| 2.72% | $3.155M 287,846 shares@ $10.96 avg price | Increased 40.46% |
RYTMRhythm Pharmaceuticals Inc
| 2.22% | $2.573M 49,120 shares@ $52.4 avg price | |
CLYMEliem Therapeutics Inc
| 2.04% | $2.36M 463,654 shares@ $5.1 avg price | New Position |
MDGLMadrigal Pharmaceuticals Inc
| 1.79% | $2.072M 9,762 shares@ $212.23 avg price | Increased 71.81% |
ASNDAscendis Pharma A S
| 1.75% | $2.031M 13,600 shares@ $149.31 avg price |